Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes #MMPMID34165438
  • Pulido-Perez P; Pondigo-de Los Angeles JA; Hernandez-Hernandez ME; Torres-Rasgado E; Romero JR
  • Magnes Res 2021[Feb]; 34 (1): 20-31 PMID34165438show ga
  • Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. In this retrospective study, we characterized 118 T2D and non-diabetic subjects hospitalized with COVID-19. Patients were clinically characterized and electrolyte, renal function and inflammatory markers were evaluated. Patients were grouped according to their estimated glomerular filtration rate (eGFR <60 mL/min per 1.73 m(2)). T2D patients had lower eGFR and serum magnesium levels when compared to non-diabetics (59.7 +/- 32.8 vs. 78.4 +/- 33.8 mL/min per 1.73 m(2), P = 0.008 and 1.9 +/- 0.3 vs. 2.1 +/- 0.3 mEq/L, P = 0.012). Survival was worse in T2D patients with eGFR levels less than 60 mL/min per 1.73 m(2) as estimated by Kaplan-Meier analyses (log-rank test <0.0001). The Cox model for T2D patients showed that eGFR (HR 0.970, 95% CI 0.949 to 0.991, P = 0.005) and magnesium (HR 8.025, 95% CI 1.226 to 52.512, P = 0.030) were associated with significantly increased risk of death. Reduced eGFR and magnesium levels were associated with increased mortality in our population. These results suggest that early assessment of kidney function, including magnesium levels, may assist in developing effective treatment strategies to reduce morbidity and mortality among Latin American COVID-19 patients with T2D.
  • |*COVID-19/blood/complications/diagnosis/mortality[MESH]
  • |*Diabetes Mellitus, Type 2/blood/complications/diagnosis/mortality[MESH]
  • |Adult[MESH]
  • |Aged[MESH]
  • |Aged, 80 and over[MESH]
  • |Biomarkers/blood[MESH]
  • |Case-Control Studies[MESH]
  • |Diabetic Nephropathies/blood/complications/diagnosis/mortality[MESH]
  • |Female[MESH]
  • |Glomerular Filtration Rate/physiology[MESH]
  • |Hospital Mortality[MESH]
  • |Humans[MESH]
  • |Kidney/metabolism/*physiopathology[MESH]
  • |Magnesium/*blood[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Prognosis[MESH]
  • |Renal Insufficiency, Chronic/blood/complications/diagnosis/mortality[MESH]
  • |Retrospective Studies[MESH]
  • |SARS-CoV-2/physiology[MESH]
  • |Survival Analysis[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    20 1.34 2021